BiotechTube
Home/Exonate/Andy Baxter
AB

Andy Baxter

Head of Product Development

Exonate

Therapeutic Areas

OphthalmologyRetinal Vascular Diseases

Exonate Pipeline

DrugIndicationPhase
EXN407Diabetic Retinopathy / Diabetic Macular OedemaPhase 2
Wet AMD ProgramWet Age-Related Macular DegenerationPre-clinical

Leadership Team at Exonate

DC
Dr Chris Torrance
Board Director
View full Exonate profile